Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    ASG-22ME | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
Condition: Metastatic Urothelial Cancer
Intervention: Drug: Enfortumab vedotin
2 Recruiting A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Condition: Metastatic Urothelial Cancer and Other Malignant Solid Tumors
Intervention: Drug: ASG-22CE

Study has passed its completion date and status has not been verified in more than two years.